Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: Pharmacogenomics of Paclitaxel in Ovarian Cancer
This Clinical Trial Update documents the completion of a pharmacogenomics study evaluating how genetic variation influences paclitaxel treat…
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: Doxil and Gemcitabine in Recurrent Ovarian Cancer [Phase 2]
Phase 2 trial evaluating Doxil (liposomal doxorubicin) with gemcitabine in recurrent ovarian cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study [Phase 2]
Phase 2 trial update of vismodegib in patients previously treated with vismodegib, with the study status completed and results posted in 201…
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: Platinum Resistant Ovarian Cancer Evaluation of Doxil and Vintafolide (MK-8109, EC145) Combination Therapy (8109-009, EC-FV-04) [Phase 2]
Phase 2 study evaluating Doxil and vintafolide for platinum-resistant ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-07Clinical Trial Update: Study of Vintafolide (MK-8109, EC145) in Participants With Advanced Ovarian and Endometrial Cancers (MK-8109-007, EC-FV-02) [Phase 2]
A Phase 2 study of vintafolide (MK-8109, EC145) in advanced ovarian and endometrial cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer [Phase 1]
Phase 1 evaluation of cisplatin plus paclitaxel in patients with advanced ovarian epithelial cancer, fallopian tube cancer, or primary perit…
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer [Phase 1]
Phase 1 trial investigating carboplatin, paclitaxel, and pegfilgrastim in patients with Stage III/IV ovarian epithelial, fallopian tube, pri…
-
CLINICAL_TRIALS trial_result · 2014-12-25Clinical Trial Update: TLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer [Phase 1]
This document reports the completion of a Phase 1 clinical trial evaluating VTX-2337, a TLR8 agonist, in combination with pegylated liposoma…
-
CLINICAL_TRIALS trial_result · 2014-12-22Clinical Trial Update: Paclitaxel and Carboplatin With Or Without Sorafenib In The First-Line Treatment Of Patients With Ovarian Cancer [Phase 2]
A Phase 2 trial evaluated first-line therapy with paclitaxel and carboplatin with or without sorafenib in ovarian cancer; the study complete…
-
CLINICAL_TRIALS trial_result · 2014-12-15Clinical Trial Update: A Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse Treatment [Phase 1, Phase 2]
Phase 1/2 study evaluating belinostat in combination with carboplatin and/or paclitaxel in relapsed ovarian cancer; results were posted in 2…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: A Randomised Placebo-Controlled Phase II Study of Continuous Maintenance Treatment With BIBF 1120 Following Chemotherapy in Patients With Relapsed Ovarian Cancer [Phase 2]
A randomized, placebo-controlled Phase II trial assessed continuous maintenance therapy with BIBF 1120 (nintedanib) after chemotherapy in re…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer [Phase 2]
Phase 2 study evaluating pertuzumab in combination with carboplatin-based chemotherapy for recurrent ovarian cancer has completed with resul…
-
CLINICAL_TRIALS trial_result · 2014-12-04Clinical Trial Update: Cabazitaxel in Platinum Refractory Ovarian Cancer [Phase 2]
A Phase 2 study of cabazitaxel in platinum-refractory ovarian cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Sunitinib in Recurrent and Refractory Ovarian, Fallopian Tube and Peritoneal Carcinoma [Phase 2]
Phase 2 trial evaluating sunitinib in recurrent and refractory ovarian, fallopian tube, and peritoneal cancer has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2014-11-27Clinical Trial Update: Dose Escalation Study of BIBF 1120 in Combination With Carboplatin and PLD in Relapsed Ovarian Cancer (OC) [Phase 1]
A Phase 1 dose-escalation trial evaluated BIBF 1120 in combination with carboplatin and pegylated liposomal doxorubicin in relapsed ovarian …
-
CLINICAL_TRIALS trial_result · 2014-11-25Clinical Trial Update: Avastin in Patients With Epithelial Ovarian, Primary Peritoneal Serous or Fallopian Tube Cancer [Phase 2]
A Phase 2 clinical trial evaluating bevacizumab (Avastin) in epithelial ovarian cancer, primary peritoneal cancer, or fallopian tube cancer;…
-
CLINICAL_TRIALS trial_result · 2014-11-24Clinical Trial Update: Individualised Versus Conventional Medical Follow-up for Women After Primary Treatment for Ovarian Cancer. [NA]
This document reports on a completed clinical trial comparing individualised follow-up versus conventional medical follow-up for women after…
-
CLINICAL_TRIALS trial_result · 2014-11-21Clinical Trial Update: Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma [Phase 2]
Phase 2 trial evaluating Ziv-aflibercept in locally advanced, unresectable, or metastatic gynecologic soft tissue sarcoma has completed with…
-
CLINICAL_TRIALS trial_result · 2014-11-20Clinical Trial Update: BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Cancer [Phase 1]
Phase 1 trial evaluating the safety of BIBF 1120 (nintedanib) in combination with Carboplatin and pegylated liposomal doxorubicin in patient…
-
CLINICAL_TRIALS trial_result · 2014-10-30Clinical Trial Update: ONSD According to the Position During Laparoscopy [NA]
A completed clinical trial update from Chosun University Hospital about optic nerve sheath diameter (ONSD) assessment during laparoscopy acr…
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Prevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC) [Phase 2]
This Phase 2 trial evaluates whether Acetyl-L-Carnitine can prevent Sagopilone-induced neurotoxicity in prostate and ovarian cancer patients…
-
CLINICAL_TRIALS trial_result · 2014-10-21Clinical Trial Update: Gleevec and Gemzar in Patients With Epithelial Ovarian Cancer [Phase 2]
A Phase 2 trial evaluating imatinib (Gleevec) and gemcitabine (Gemzar) in patients with epithelial ovarian cancer and primary peritoneal can…
-
CLINICAL_TRIALS trial_result · 2014-10-20Clinical Trial Update: Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma [Phase 2]
Phase 2 trial of pemetrexed plus bevacizumab for recurrent ovarian cancer and primary peritoneal cancer has completed; results were posted i…
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: A Trial Evaluating Efficacy and Safety of Oxaliplatin With 5-Fluorouracil in Patients With Recurrent Ovarian Carcinoma [Phase 2]
Phase 2 trial assessing the efficacy and safety of oxaliplatin plus 5-fluorouracil in patients with recurrent ovarian cancer, with the study…
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: Imaging of Peritoneal Carcinomatosis From Ovarian Carcinoma Patients [Phase 1, Phase 2]
A clinical trial update on imaging for peritoneal carcinomatosis in ovarian cancer patients, spanning Phase 1 and Phase 2, which has complet…